Japan Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Vaccine market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Novartis AG

    • Takeda Pharmaceuticals

    • Merck & Co Inc.

    • Mitsubishi Tanabe

    • Sanofi

    • Merck & Co. Inc

    • Astellas Pharma Inc.

    • GlaxoSmithKline plc

    • Pfizer Inc

    • Emergent BioSolutions


    By Type:

    • Dengue Vaccine

    • Chikungunya Vaccine

    • MR Vaccine

    • TD Vaccine

    • Hepatitis A vaccine

    • Zika Vaccine

    • Typhoid Conjugate Vaccine


    By End-User:

    • Infectious diseases

    • Cancer

    • Autism

    • Allergy

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Vaccine Market Size and Growth Rate of Dengue Vaccine from 2014 to 2026

      • 1.3.2 Japan Vaccine Market Size and Growth Rate of Chikungunya Vaccine from 2014 to 2026

      • 1.3.3 Japan Vaccine Market Size and Growth Rate of MR Vaccine from 2014 to 2026

      • 1.3.4 Japan Vaccine Market Size and Growth Rate of TD Vaccine from 2014 to 2026

      • 1.3.5 Japan Vaccine Market Size and Growth Rate of Hepatitis A vaccine from 2014 to 2026

      • 1.3.6 Japan Vaccine Market Size and Growth Rate of Zika Vaccine from 2014 to 2026

      • 1.3.7 Japan Vaccine Market Size and Growth Rate of Typhoid Conjugate Vaccine from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Vaccine Market Size and Growth Rate of Infectious diseases from 2014 to 2026

      • 1.4.2 Japan Vaccine Market Size and Growth Rate of Cancer from 2014 to 2026

      • 1.4.3 Japan Vaccine Market Size and Growth Rate of Autism from 2014 to 2026

      • 1.4.4 Japan Vaccine Market Size and Growth Rate of Allergy from 2014 to 2026

      • 1.4.5 Japan Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Vaccine Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Dengue Vaccine

      • 3.4.2 Market Size and Growth Rate of Chikungunya Vaccine

      • 3.4.3 Market Size and Growth Rate of MR Vaccine

      • 3.4.4 Market Size and Growth Rate of TD Vaccine

      • 3.4.5 Market Size and Growth Rate of Hepatitis A vaccine

      • 3.4.6 Market Size and Growth Rate of Zika Vaccine

      • 3.4.7 Market Size and Growth Rate of Typhoid Conjugate Vaccine


    4 Segmentation of Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Vaccine in Infectious diseases

      • 4.4.2 Market Size and Growth Rate of Vaccine in Cancer

      • 4.4.3 Market Size and Growth Rate of Vaccine in Autism

      • 4.4.4 Market Size and Growth Rate of Vaccine in Allergy

      • 4.4.5 Market Size and Growth Rate of Vaccine in Others


    5 Market Analysis by Regions

    • 5.1 Japan Vaccine Production Analysis by Regions

    • 5.2 Japan Vaccine Consumption Analysis by Regions


    6 Hokkaido Vaccine Landscape Analysis

    • 6.1 Hokkaido Vaccine Landscape Analysis by Major Types

    • 6.2 Hokkaido Vaccine Landscape Analysis by Major End-Users


    7 Tohoku Vaccine Landscape Analysis

    • 7.1 Tohoku Vaccine Landscape Analysis by Major Types

    • 7.2 Tohoku Vaccine Landscape Analysis by Major End-Users


    8 Kanto Vaccine Landscape Analysis

    • 8.1 Kanto Vaccine Landscape Analysis by Major Types

    • 8.2 Kanto Vaccine Landscape Analysis by Major End-Users


    9 Chubu Vaccine Landscape Analysis

    • 9.1 Chubu Vaccine Landscape Analysis by Major Types

    • 9.2 Chubu Vaccine Landscape Analysis by Major End-Users


    10 Kinki Vaccine Landscape Analysis

    • 10.1 Kinki Vaccine Landscape Analysis by Major Types

    • 10.2 Kinki Vaccine Landscape Analysis by Major End-Users


    11 Chugoku Vaccine Landscape Analysis

    • 11.1 Chugoku Vaccine Landscape Analysis by Major Types

    • 11.2 Chugoku Vaccine Landscape Analysis by Major End-Users


    12 Shikoku Vaccine Landscape Analysis

    • 12.1 Shikoku Vaccine Landscape Analysis by Major Types

    • 12.2 Shikoku Vaccine Landscape Analysis by Major End-Users


    13 Kyushu Vaccine Landscape Analysis

    • 13.1 Kyushu Vaccine Landscape Analysis by Major Types

    • 13.2 Kyushu Vaccine Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Novartis AG

      • 14.1.1 Novartis AG Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Takeda Pharmaceuticals

      • 14.2.1 Takeda Pharmaceuticals Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Merck & Co Inc.

      • 14.3.1 Merck & Co Inc. Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Mitsubishi Tanabe

      • 14.4.1 Mitsubishi Tanabe Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Merck & Co. Inc

      • 14.6.1 Merck & Co. Inc Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Astellas Pharma Inc.

      • 14.7.1 Astellas Pharma Inc. Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 GlaxoSmithKline plc

      • 14.8.1 GlaxoSmithKline plc Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Pfizer Inc

      • 14.9.1 Pfizer Inc Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Emergent BioSolutions

      • 14.10.1 Emergent BioSolutions Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 118 Figures and 121 Tables)

     

    • Figure Japan Vaccine Market Size and Growth Rate of Dengue Vaccine from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Chikungunya Vaccine from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of MR Vaccine from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of TD Vaccine from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Hepatitis A vaccine from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Zika Vaccine from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Typhoid Conjugate Vaccine from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Infectious diseases from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Autism from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Allergy from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Dengue Vaccine

    • Figure Market Size and Growth Rate of Chikungunya Vaccine

    • Figure Market Size and Growth Rate of MR Vaccine

    • Figure Market Size and Growth Rate of TD Vaccine

    • Figure Market Size and Growth Rate of Hepatitis A vaccine

    • Figure Market Size and Growth Rate of Zika Vaccine

    • Figure Market Size and Growth Rate of Typhoid Conjugate Vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Vaccine by Different End-Users from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Infectious diseases from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Autism from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Allergy from 2014 to 2026

    • Figure Japan Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Vaccine Production by Regions

    • Table Japan Vaccine Production Share by Regions

    • Figure Japan Vaccine Production Share by Regions in 2014

    • Figure Japan Vaccine Production Share by Regions in 2018

    • Figure Japan Vaccine Production Share by Regions in 2026

    • Table Japan Vaccine Consumption by Regions

    • Table Japan Vaccine Consumption Share by Regions

    • Figure Japan Vaccine Consumption Share by Regions in 2014

    • Figure Japan Vaccine Consumption Share by Regions in 2018

    • Figure Japan Vaccine Consumption Share by Regions in 2026

    • Table Hokkaido Vaccine Consumption by Types from 2014 to 2026

    • Table Hokkaido Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Vaccine Consumption Share by Types in 2014

    • Figure Hokkaido Vaccine Consumption Share by Types in 2018

    • Figure Hokkaido Vaccine Consumption Share by Types in 2026

    • Table Hokkaido Vaccine Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Vaccine Consumption Share by End-Users in 2014

    • Figure Hokkaido Vaccine Consumption Share by End-Users in 2018

    • Figure Hokkaido Vaccine Consumption Share by End-Users in 2026

    • Table Tohoku Vaccine Consumption by Types from 2014 to 2026

    • Table Tohoku Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Vaccine Consumption Share by Types in 2014

    • Figure Tohoku Vaccine Consumption Share by Types in 2018

    • Figure Tohoku Vaccine Consumption Share by Types in 2026

    • Table Tohoku Vaccine Consumption by End-Users from 2014 to 2026

    • Table Tohoku Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Vaccine Consumption Share by End-Users in 2014

    • Figure Tohoku Vaccine Consumption Share by End-Users in 2018

    • Figure Tohoku Vaccine Consumption Share by End-Users in 2026

    • Table Kanto Vaccine Consumption by Types from 2014 to 2026

    • Table Kanto Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kanto Vaccine Consumption Share by Types in 2014

    • Figure Kanto Vaccine Consumption Share by Types in 2018

    • Figure Kanto Vaccine Consumption Share by Types in 2026

    • Table Kanto Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kanto Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Vaccine Consumption Share by End-Users in 2014

    • Figure Kanto Vaccine Consumption Share by End-Users in 2018

    • Figure Kanto Vaccine Consumption Share by End-Users in 2026

    • Table Chubu Vaccine Consumption by Types from 2014 to 2026

    • Table Chubu Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chubu Vaccine Consumption Share by Types in 2014

    • Figure Chubu Vaccine Consumption Share by Types in 2018

    • Figure Chubu Vaccine Consumption Share by Types in 2026

    • Table Chubu Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chubu Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Vaccine Consumption Share by End-Users in 2014

    • Figure Chubu Vaccine Consumption Share by End-Users in 2018

    • Figure Chubu Vaccine Consumption Share by End-Users in 2026

    • Table Kinki Vaccine Consumption by Types from 2014 to 2026

    • Table Kinki Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kinki Vaccine Consumption Share by Types in 2014

    • Figure Kinki Vaccine Consumption Share by Types in 2018

    • Figure Kinki Vaccine Consumption Share by Types in 2026

    • Table Kinki Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kinki Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Vaccine Consumption Share by End-Users in 2014

    • Figure Kinki Vaccine Consumption Share by End-Users in 2018

    • Figure Kinki Vaccine Consumption Share by End-Users in 2026

    • Table Chugoku Vaccine Consumption by Types from 2014 to 2026

    • Table Chugoku Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Vaccine Consumption Share by Types in 2014

    • Figure Chugoku Vaccine Consumption Share by Types in 2018

    • Figure Chugoku Vaccine Consumption Share by Types in 2026

    • Table Chugoku Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chugoku Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Vaccine Consumption Share by End-Users in 2014

    • Figure Chugoku Vaccine Consumption Share by End-Users in 2018

    • Figure Chugoku Vaccine Consumption Share by End-Users in 2026

    • Table Shikoku Vaccine Consumption by Types from 2014 to 2026

    • Table Shikoku Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Vaccine Consumption Share by Types in 2014

    • Figure Shikoku Vaccine Consumption Share by Types in 2018

    • Figure Shikoku Vaccine Consumption Share by Types in 2026

    • Table Shikoku Vaccine Consumption by End-Users from 2014 to 2026

    • Table Shikoku Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Vaccine Consumption Share by End-Users in 2014

    • Figure Shikoku Vaccine Consumption Share by End-Users in 2018

    • Figure Shikoku Vaccine Consumption Share by End-Users in 2026

    • Table Kyushu Vaccine Consumption by Types from 2014 to 2026

    • Table Kyushu Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Vaccine Consumption Share by Types in 2014

    • Figure Kyushu Vaccine Consumption Share by Types in 2018

    • Figure Kyushu Vaccine Consumption Share by Types in 2026

    • Table Kyushu Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kyushu Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Vaccine Consumption Share by End-Users in 2014

    • Figure Kyushu Vaccine Consumption Share by End-Users in 2018

    • Figure Kyushu Vaccine Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

    • Table Company Profile and Development Status of Merck & Co Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc.

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc.

    • Figure Revenue and Market Share Analysis of Merck & Co Inc.

    • Table Product and Service Introduction of Merck & Co Inc.

    • Table Company Profile and Development Status of Mitsubishi Tanabe

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe

    • Table Product and Service Introduction of Mitsubishi Tanabe

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Merck & Co. Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co. Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co. Inc

    • Figure Revenue and Market Share Analysis of Merck & Co. Inc

    • Table Product and Service Introduction of Merck & Co. Inc

    • Table Company Profile and Development Status of Astellas Pharma Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma Inc.

    • Figure Sales and Growth Rate Analysis of Astellas Pharma Inc.

    • Figure Revenue and Market Share Analysis of Astellas Pharma Inc.

    • Table Product and Service Introduction of Astellas Pharma Inc.

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Emergent BioSolutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions

    • Table Product and Service Introduction of Emergent BioSolutions

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.